Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
ITGB2 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
Latest Hotspot
8 min read
ITGB2 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
ITGB2 target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, competition, IP and R&D strategy.
Read →
CXCR4 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
CXCR4 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
CXCR4 target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, competition, IP and R&D strategy.
Read →
EPCAM Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
EPCAM Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
EPCAM target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, competition, IP and R&D strategy.
Read →
MUC1 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
Latest Hotspot
8 min read
MUC1 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
MUC1 target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, competition, IP and R&D strategy.
Read →
CD40 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
Latest Hotspot
8 min read
CD40 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
CD40 target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, competition, IP and R&D strategy.
Read →
TNFRSF18 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
Latest Hotspot
8 min read
TNFRSF18 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
TNFRSF18 target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, competition, IP and R&D strategy.
Read →
TNFRSF9 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
Latest Hotspot
8 min read
TNFRSF9 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
TNFRSF9 target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, competition, IP and R&D strategy.
Read →
TNFRSF4 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
Latest Hotspot
8 min read
TNFRSF4 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
TNFRSF4 target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, competition, IP and R&D strategy.
Read →
IL2RA Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
Latest Hotspot
8 min read
IL2RA Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
IL2RA target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, competition, IP and R&D strategy.
Read →
ARG1 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
Latest Hotspot
8 min read
ARG1 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
ARG1 target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, competition, IP and R&D strategy.
Read →
CSF1R Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
Latest Hotspot
8 min read
CSF1R Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
CSF1R target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, competition, IP and R&D strategy.
Read →
IDO1 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
Latest Hotspot
8 min read
IDO1 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
IDO1 target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, competition, IP and R&D strategy.
Read →